Skip to main content
| News

Startups from the Basel Area ranked among the best

11.09.2020

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech company Resistell was even voted among the top ten best startups in Switzerland.

Venturelab has organized the TOP 100 Swiss Startup Award for the tenth time. Switzerland’s 100 most-innovative and promising startups have been selected by a jury of 100 leading investors and startup experts.

Several startups from the Basel Area have been included in this year’s TOP 100 list. The medtech startup Resistell has made a huge leap forward. Having taken 34th place in the previous year, it is now ranked in 8th position, making it the best-placed company in the Basel Area too. Moreover, Resistell was named Switzerland’s second-best startup in the Medtech category. The company, which is headquartered in Basel, is developing a particularly rapid test against antibiotic resistance. It has received support from Basel Area Business & Innovation.

Coming in 15th place, Tolremo Therapeutics from Muttenz in the canton of Basel-Landschaft achieved the second-best ranking of companies located in the Basel Area. The biotech firm is developing cancer therapies for precision medicine. In June this year, the company raised a total of 4.7 million Swiss francs as part of a financing round. Now, the company is focused on advancing clinical development. Tolremo is currently being supported by the BaseLaunch accelerator and incubator.

PharmaBiome was ranked in 27th position. The company develops therapies for bowel conditions and is represented by way of a subsidiary located at Switzerland Innovation Park Basel Area at the site in Allschwil in the canton of Basel-Landschaft. The company is also presently being supported by BaseLaunch.

In addition, the Basel-based biopharmaceutical company Versameb achieved 49th place in the rankings, with another biotech company from Basel, namely T3 Pharmaceuticals, in 52nd place. Moreover, the biotech firm Perseo pharma from Basel took 60th place, while Anaveon, a biotech company from Basel, and the Basel-based ICT firm MyCamper, both snuck into the TOP 100 list, taking 89th and 98th place respectively. With the exception of Perseo pharma and MyCamper, all of these startups were supported by BaseLaunch.

Furthermore the Aargau-based software company holo one AG, which was supported by the i4Challenge of Basel Area Business & Innovation, also made it into the TOP 100 list.

In the public vote ranking, the two Basel-based companies KetoSwiss and Lyfegen HealthTech were ranked among the top ten.

Last year, Polyneuron was the best-placed company from the Basel Area in 14th place. Since then, Polyneuron has grown further and is now included in the Scaleup ranking from Venturelab. This recognises successful startups founded more than five years ago. Among other things, Polyneuron is developing an active ingredient to treat the autoimmune disease Anti-MAG peripheral neuropathy and has received support from the BaseLaunch accelerator and incubator as well.

Polyneuron, Anaveon, Perseo pharma and Versameb are currently based in the Technologiepark Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 55

Do you have a question? We'd like to hear from you.